Emergency Medicine’s #1 Journal Publication: Clinical advances and trends from the most trusted emergency medical news source in emergency medicine.
Emergency Medicine News - Procalcitonin: Risk Assessment in COVID-19 Bacterial Co-Infection-Sponsored by Thermo Fisher Scientific
Claim This Podcastby Emergency Medicine News
1.0(1 reviews)
1 episodes
Updated Daily
Accepts GuestsHas Sponsors
Podcast Overview
Emergency Medicine’s #1 Journal Publication: Clinical advances and trends from the most trusted emergency medical news source in emergency medicine.
Language
🇺🇲
Publishing Since
6/9/2020
1 verified contact email on file for Emergency Medicine News - Procalcitonin: Risk Assessment in COVID-19 Bacterial Co-Infection-Sponsored by Thermo Fisher Scientific
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
June 9, 2020
Procalcitonin: Risk Assessment in COVID-19 Bacterial Co-Infection
Sherrie Smartt, RN, MSN, Medical Director of Clinical Studies and Regulatory Affairs Manager for Thermo Fisher Diagnostic Biomarkers, interviews Eric H. Gluck MD, Director of Critical Care Services at Swedish Covenant Hospital, Professor of Medicine at Finch University of Health Sciences, an author of the foundation for the MOSES trial, which expanded the procalcitonin FDA claim, and a member on PCT-Guided Antibiotic Therapy in Hospitals, and Mike Broyles, PharmD, a hospital pharmacy and laboratory director focusing on antimicrobial stewardship and consultant for a large IDN as pharmacy advisory chairman for more than 25 years, who is also on the Board for Thermo Fisher Scientific, Roche Diagnostics, bioMerieux, Fujirebio, Abbott Diagnostics, and ICNet, and a member on PCT-Guided Antibiotic Therapy in Hospitals.<br><br> Sponsored by Thermo Fisher Scientific
1 total episodes available
Deep-dive analytics for Emergency Medicine News - Procalcitonin: Risk Assessment in COVID-19 Bacterial Co-Infection-Sponsored by Thermo Fisher Scientific
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Emergency Medicine News - Procalcitonin: Risk Assessment in COVID-19 Bacterial Co-Infection-Sponsored by Thermo Fisher Scientific?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.